Charles River Laboratories International, Inc.
CRL
$178.14
$2.221.26%
| 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -407.93% | -25.96% | 28.95% | -61.00% | 114.08% |
| Total Depreciation and Amortization | 5.11% | 2.46% | 0.85% | 6.02% | 2.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,341.46% | -9.14% | 25.64% | 123.12% | -330.58% |
| Change in Net Operating Assets | -159.30% | 730.88% | 76.44% | -225.28% | 1,563.30% |
| Cash from Operations | -36.71% | 30.10% | 49.00% | -41.21% | 7.54% |
| Capital Expenditure | -95.28% | 1.94% | 50.11% | -1.05% | -18.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -102.81% | 202.93% | -154.23% | 56.91% | -13.37% |
| Cash from Investing | -256.89% | 65.53% | 27.89% | 64.01% | -199.62% |
| Total Debt Issued | -55.52% | -46.50% | 46.34% | -32.13% | 765.22% |
| Total Debt Repaid | 46.37% | 52.56% | -137.57% | 8.82% | -49.99% |
| Issuance of Common Stock | -1.41% | -5.69% | -96.16% | 262.10% | 50.77% |
| Repurchase of Common Stock | 99.88% | -1,030.65% | 4.67% | -6,627.34% | -265.79% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 66.27% | 42.02% | -951.90% | 53.85% | -15.42% |
| Cash from Financing | 63.44% | 27.40% | -1,658.15% | -85.15% | 175.87% |
| Foreign Exchange rate Adjustments | -274.57% | 330.52% | 60.15% | -165.91% | 305.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.81% | 119.45% | -391.43% | -54.52% | 375.40% |
